منابع مشابه
Oesophageal cancer: preoperative chemotherapy.
The optimal management of localised oesophageal cancer remains controversial. Indeed, currently utilised strategies are clearly unsatisfactory, given that most randomised trials report overall 5-year survivals of 20% or less for patients undergoing surgical resection. The rationale behind preoperative chemotherapy is two-fold: (i) to downstage or downsize the primary tumour in order to ensure c...
متن کاملBevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases
This study aimed to assess the efficacy and safety of bevacizumab plus preoperative chemotherapy as first-line treatment for liver-only metastatic colorectal cancer in Chinese patients compared with those of preoperative chemotherapy alone.Patients with histologically confirmed liver-only metastatic colorectal cancer were sequentially reviewed, and received either preoperative chemotherapy plus...
متن کاملDifferential Network Analysis Applied to Preoperative Breast Cancer Chemotherapy Response
In silico approaches are increasingly considered to improve breast cancer treatment. One of these treatments, neoadjuvant TFAC chemotherapy, is used in cases where application of preoperative systemic therapy is indicated. Estimating response to treatment allows or improves clinical decision-making and this, in turn, may be based on a good understanding of the underlying molecular mechanisms. E...
متن کاملBreast cancer molecular subtypes respond differently to preoperative chemotherapy.
PURPOSE Molecular classification of breast cancer has been proposed based on gene expression profiles of human tumors. Luminal, basal-like, normal-like, and erbB2+ subgroups were identified and were shown to have different prognoses. The goal of this research was to determine if these different molecular subtypes of breast cancer also respond differently to preoperative chemotherapy. EXPERIME...
متن کاملPostoperative and Preoperative Chemotherapy for Non-Small Cell Lung Cancer.
BACKGROUND: Few randomized trials of preoperative and postoperative adjuvant systemic therapy have been performed in patients with non-small-cell lung cancer (NSCLC). METHODS: The authors reviewed the recent literature on comparative trials and meta-analyses to determine the current status of adjuvant therapy for patients with NSCLC. RESULTS: Postoperative adjuvant therapy with cisplatin-contai...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Practica Oto-Rhino-Laryngologica
سال: 1985
ISSN: 1884-4545,0032-6313
DOI: 10.5631/jibirin.78.698